OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE was reported 182 times

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACARIASIS 1 0.0714
1 INTESTINAL INTRAEPITHELIAL LYMPHOCYTES INCREASED 2 0.0299
2 PRODUCT DESICCANT ISSUE 1 0.0294
3 LYMPHANGIECTASIA INTESTINAL 1 0.0200
4 RADIATION ASSOCIATED HAEMORRHAGE 1 0.0169
5 ANGIOMYOLIPOMA 1 0.0047
6 PLANTAR ERYTHEMA 1 0.0040
7 GASTROINTESTINAL MUCOSA HYPERAEMIA 1 0.0034
8 OROPHARYNGEAL PLAQUE 1 0.0025
9 INTESTINAL VILLI ATROPHY 1 0.0024
10 INFUSION SITE SCAR 1 0.0023
11 NAIL INJURY 1 0.0018
12 SPONDYLOARTHROPATHY 1 0.0017
13 GASTROINTESTINAL EROSION 1 0.0016
14 STASIS DERMATITIS 1 0.0015
15 ANGULAR CHEILITIS 1 0.0014
16 PRODUCT DESIGN ISSUE 1 0.0014
17 PALMOPLANTAR KERATODERMA 1 0.0014
18 BLOOD FOLATE DECREASED 1 0.0014
19 PHILADELPHIA CHROMOSOME POSITIVE 1 0.0014
20 HEPATITIS VIRAL 1 0.0012
21 NECROTISING MYOSITIS 1 0.0012
22 BUNDLE BRANCH BLOCK 1 0.0011
23 BLOOD UREA ABNORMAL 1 0.0011
24 SPRUE-LIKE ENTEROPATHY 5 0.0010
25 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
26 BONE DEMINERALISATION 1 0.0009
27 OTITIS EXTERNA 1 0.0008
28 BLADDER DISCOMFORT 1 0.0008
29 HYPERAESTHESIA TEETH 1 0.0008
30 INFUSION SITE IRRITATION 1 0.0008
31 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
32 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
33 INFUSION SITE INDURATION 1 0.0007
34 PELVIC INFLAMMATORY DISEASE 1 0.0007
35 MEDICAL DEVICE IMPLANTATION 1 0.0006
36 TONSILLAR HYPERTROPHY 1 0.0006
37 AORTIC STENOSIS 2 0.0006
38 PRODUCT ODOUR ABNORMAL 6 0.0006
39 POLYMYOSITIS 1 0.0006
40 BLADDER SPASM 1 0.0005
41 ARTERIAL DISORDER 1 0.0005
42 MOTION SICKNESS 1 0.0005
43 ATROPHY 1 0.0005
44 TORTICOLLIS 1 0.0005
45 COLONOSCOPY 1 0.0005
46 CHRONIC GASTRITIS 1 0.0004
47 INFUSION SITE INFECTION 1 0.0004
48 NECK SURGERY 1 0.0004
49 RADIUS FRACTURE 1 0.0004
50 PAINFUL RESPIRATION 1 0.0004
51 CATHETER SITE HAEMORRHAGE 1 0.0004
52 ANGLE CLOSURE GLAUCOMA 1 0.0004
53 MALABSORPTION 2 0.0004
54 IMMUNE-MEDIATED MYOSITIS 1 0.0004
55 SKIN HYPERTROPHY 1 0.0004
56 OXYGEN SATURATION ABNORMAL 1 0.0004
57 HEART VALVE INCOMPETENCE 1 0.0003
58 VITAMIN B12 DECREASED 1 0.0003
59 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
60 MASTICATION DISORDER 1 0.0003
61 INJECTION SITE INFECTION 1 0.0003
62 INFUSION SITE HAEMORRHAGE 1 0.0003
63 HEPATIC CYST 1 0.0003
64 APPENDICECTOMY 1 0.0003
65 PARANASAL SINUS HYPERSECRETION 1 0.0003
66 POLYDIPSIA 1 0.0003
67 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
68 GENERALISED OEDEMA 3 0.0002
69 TONGUE DISCOMFORT 1 0.0002
70 POOR PERIPHERAL CIRCULATION 1 0.0002
71 INTERVERTEBRAL DISC DISORDER 1 0.0002
72 TOOTH INJURY 1 0.0002
73 PRODUCT TASTE ABNORMAL 3 0.0002
74 URINE ABNORMALITY 1 0.0002
75 SUSPECTED SUICIDE 1 0.0002
76 SQUAMOUS CELL CARCINOMA 2 0.0002
77 HYPOVOLAEMIC SHOCK 1 0.0002
78 MUCOUS STOOLS 1 0.0002
79 HYPERNATRAEMIA 1 0.0002
80 PRODUCT COLOUR ISSUE 1 0.0002
81 BASAL CELL CARCINOMA 3 0.0002
82 BRAIN FOG 3 0.0002
83 INJECTION SITE DISCHARGE 1 0.0002
84 DEAFNESS UNILATERAL 1 0.0002
85 HYPERKERATOSIS 1 0.0002
86 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
87 INJECTION SITE INJURY 1 0.0002
88 BRADYKINESIA 1 0.0002
89 PROTHROMBIN TIME PROLONGED 1 0.0002
90 TENSION 1 0.0002
91 OLIGURIA 1 0.0002
92 INFUSION SITE PAIN 2 0.0002
93 HEPATITIS ACUTE 1 0.0002
94 WALKING AID USER 1 0.0002
95 SOPOR 2 0.0002
96 SKIN MASS 1 0.0001
97 GINGIVAL BLEEDING 2 0.0001
98 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
99 ENCEPHALITIS 1 0.0001
100 DIVERTICULUM 1 0.0001
101 ORAL DISORDER 1 0.0001
102 SENSITIVE SKIN 1 0.0001
103 FOOD ALLERGY 1 0.0001
104 HYPOALBUMINAEMIA 1 0.0001
105 PELVIC FRACTURE 1 0.0001
106 ATRIAL FLUTTER 1 0.0001
107 POLYURIA 1 0.0001
108 HYPERAESTHESIA 1 0.0001
109 INFUSION SITE ERYTHEMA 1 0.0001
110 FACIAL PARALYSIS 1 0.0001
111 MUSCULOSKELETAL DISCOMFORT 2 0.0001
112 ANURIA 1 0.0001
113 BLOOD MAGNESIUM DECREASED 1 0.0001
114 PURPURA 1 0.0001
115 FACIAL PAIN 1 0.0001
116 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
117 HEAVY MENSTRUAL BLEEDING 1 0.0001
118 PRODUCT DISTRIBUTION ISSUE 1 0.0001
119 DEFORMITY 1 0.0001
120 FLANK PAIN 1 0.0001
121 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
122 ATELECTASIS 1 0.0001
123 HAEMORRHOIDS 2 0.0001
124 COELIAC DISEASE 1 0.0001
125 EMBEDDED DEVICE 1 0.0001
126 TOXIC SKIN ERUPTION 1 0.0001
127 PRODUCT PHYSICAL ISSUE 2 0.0001
128 INTENTIONAL SELF-INJURY 2 0.0001
129 SLUGGISHNESS 1 0.0001
130 POLLAKIURIA 4 0.0001
131 INCONTINENCE 1 0.0001
132 TOOTH FRACTURE 1 0.0001
133 OCULAR DISCOMFORT 1 0.0001
134 REBOUND EFFECT 1 0.0001
135 POST PROCEDURAL HAEMORRHAGE 1 0.0001
136 BLOOD IRON DECREASED 1 0.0001
137 WRIST FRACTURE 1 0.0001
138 NOCTURIA 1 0.0001
139 PRESYNCOPE 2 0.0001
140 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
141 CYST 1 0.0001
142 HOT FLUSH 6 0.0001
143 MUSCLE ATROPHY 1 0.0001
144 INJECTION SITE IRRITATION 1 0.0001
145 NODULE 1 0.0001
146 TOOTH INFECTION 1 0.0001
147 SARS-COV-2 TEST POSITIVE 1 0.0001
148 TACHYPNOEA 1 0.0001
149 APPLICATION SITE RASH 1 0.0001
150 RHABDOMYOLYSIS 3 0.0001
151 MASS 1 0.0001
152 SEASONAL ALLERGY 1 0.0001
153 NEEDLE ISSUE 2 0.0001
154 URINARY INCONTINENCE 2 0.0001
155 PULMONARY MASS 1 0.0001
156 BONE LOSS 1 0.0001
157 OSTEOPENIA 1 0.0001
158 HYPOKALAEMIA 3 0.0001
159 THERAPY PARTIAL RESPONDER 1 0.0001
160 SWOLLEN TONGUE 2 0.0001
161 METABOLIC ACIDOSIS 2 0.0001
162 MOVEMENT DISORDER 2 0.0001
163 BLOOD POTASSIUM INCREASED 1 0.0001
164 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
165 URINARY RETENTION 2 0.0001
166 EYE PRURITUS 2 0.0001
167 SCAR 1 0.0001
168 DERMATITIS ATOPIC 3 0.0001
169 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
170 SYNOVITIS 1 0.0001
171 COMPLICATION OF DEVICE REMOVAL 1 0.0001
172 TOOTHACHE 1 0.0001
173 TREATMENT NONCOMPLIANCE 3 0.0001
174 MIDDLE INSOMNIA 1 0.0001
175 PHOTOPHOBIA 1 0.0001
176 BLOOD SODIUM DECREASED 1 0.0001
177 FOOT FRACTURE 1 0.0001
178 BLOOD URINE PRESENT 1 0.0001
179 PRODUCT SUBSTITUTION ISSUE 3 0.0001
180 SEROTONIN SYNDROME 1 0.0001
181 BONE PAIN 3 0.0001
182 SKIN FISSURES 1 0.0001
183 SPINAL FRACTURE 1 0.0000
184 FULL BLOOD COUNT DECREASED 1 0.0000
185 TASTE DISORDER 1 0.0000
186 PSORIATIC ARTHROPATHY 2 0.0000
187 DISCOMFORT 3 0.0000
188 DRUG ABUSE 4 0.0000
189 MOUTH ULCERATION 1 0.0000
190 HYPOACUSIS 2 0.0000
191 PRODUCT PRESCRIBING ISSUE 1 0.0000
192 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
193 RASH MACULO-PAPULAR 1 0.0000
194 HEPATOTOXICITY 1 0.0000
195 ORAL PAIN 1 0.0000
196 HEART RATE IRREGULAR 1 0.0000
197 APPLICATION SITE PRURITUS 1 0.0000
198 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
199 TINNITUS 2 0.0000
200 SKIN DISCOLOURATION 2 0.0000
201 RENAL DISORDER 2 0.0000
202 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
203 OCULAR HYPERAEMIA 2 0.0000
204 BLOOD GLUCOSE DECREASED 2 0.0000
205 MENTAL IMPAIRMENT 1 0.0000
206 NEURALGIA 1 0.0000
207 BRONCHITIS 3 0.0000
208 SYNCOPE 4 0.0000
209 FLUID RETENTION 2 0.0000
210 PERIPHERAL SWELLING 6 0.0000
211 ERECTILE DYSFUNCTION 1 0.0000
212 ILLNESS 4 0.0000
213 PSORIASIS 5 0.0000
214 SEDATION 1 0.0000
215 APPLICATION SITE ERYTHEMA 1 0.0000
216 JOINT STIFFNESS 1 0.0000
217 ANHEDONIA 1 0.0000
218 GASTRITIS 1 0.0000
219 EAR INFECTION 1 0.0000
220 ASTHENIA 14 0.0000
221 FREQUENT BOWEL MOVEMENTS 1 0.0000
222 CARDIAC ARREST 3 0.0000
223 RESPIRATORY ARREST 1 0.0000
224 DIVERTICULITIS 1 0.0000
225 PROCEDURAL PAIN 1 0.0000
226 MENTAL STATUS CHANGES 1 0.0000
227 COMPLETED SUICIDE 3 0.0000
228 PAIN IN JAW 1 0.0000
229 INTENTIONAL DOSE OMISSION 1 0.0000
230 HYPERSOMNIA 1 0.0000
231 BALANCE DISORDER 3 0.0000
232 DYSSTASIA 1 0.0000
233 SURGERY 2 0.0000
234 ASCITES 1 0.0000
235 TACHYCARDIA 3 0.0000
236 GASTROINTESTINAL DISORDER 3 0.0000
237 BLOOD POTASSIUM DECREASED 1 0.0000
238 APHASIA 1 0.0000
239 HYPERTENSION 7 0.0000
240 VERTIGO 2 0.0000
241 SWELLING 3 0.0000
242 NERVOUS SYSTEM DISORDER 1 0.0000
243 HEAD INJURY 1 0.0000
244 GAIT DISTURBANCE 6 0.0000
245 INTENTIONAL OVERDOSE 2 0.0000
246 HIP FRACTURE 1 0.0000
247 CONFUSIONAL STATE 5 0.0000
248 LACTIC ACIDOSIS 1 0.0000
249 BLOOD CREATININE INCREASED 2 0.0000
250 DYSPEPSIA 3 0.0000
251 DECREASED APPETITE 7 0.0000
252 VIRAL INFECTION 1 0.0000
253 FUNGAL INFECTION 1 0.0000
254 DRY SKIN 4 0.0000
255 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
256 HEPATIC ENZYME INCREASED 2 0.0000
257 FEELING ABNORMAL 7 0.0000
258 HAEMATURIA 1 0.0000
259 INJECTION SITE REACTION 2 0.0000
260 DEVICE USE ERROR 1 0.0000
261 BURNING SENSATION 2 0.0000
262 DEVICE MALFUNCTION 2 0.0000
263 CEREBRAL HAEMORRHAGE 1 0.0000
264 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
265 C-REACTIVE PROTEIN INCREASED 1 0.0000
266 HYPERGLYCAEMIA 1 0.0000
267 PRODUCT DOSE OMISSION ISSUE 8 0.0000
268 INJECTION SITE MASS 1 0.0000
269 CHEST PAIN 5 0.0000
270 DYSGEUSIA 2 0.0000
271 HYPOAESTHESIA 4 0.0000
272 DYSPNOEA EXERTIONAL 1 0.0000
273 MUSCULAR WEAKNESS 3 0.0000
274 BLOOD PRESSURE INCREASED 4 0.0000
275 INJECTION SITE SWELLING 2 0.0000
276 EXTRA DOSE ADMINISTERED 1 0.0000
277 DEVICE BREAKAGE 1 0.0000
278 OEDEMA PERIPHERAL 3 0.0000
279 DYSKINESIA 1 0.0000
280 NEUTROPHIL COUNT DECREASED 1 0.0000
281 INJECTION SITE ERYTHEMA 3 0.0000
282 DIZZINESS 12 0.0000
283 SKIN EXFOLIATION 2 0.0000
284 OSTEOARTHRITIS 1 0.0000
285 MYALGIA 4 0.0000
286 RECTAL HAEMORRHAGE 1 0.0000
287 DIARRHOEA 15 0.0000
288 DEVICE LEAKAGE 1 0.0000
289 MENTAL DISORDER 1 0.0000
290 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
291 ANGIOEDEMA 1 0.0000
292 COLITIS ULCERATIVE 1 0.0000
293 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
294 MEMORY IMPAIRMENT 3 0.0000
295 FATIGUE 17 0.0000
296 WEIGHT DECREASED 6 0.0000
297 BREAST CANCER 2 0.0000
298 CARDIAC DISORDER 2 0.0000
299 PULMONARY EMBOLISM 2 0.0000
300 ANAEMIA 4 0.0000
301 MULTIPLE SCLEROSIS 1 0.0000
302 HYPOGLYCAEMIA 1 0.0000
303 LUNG DISORDER 1 0.0000
304 SINUSITIS 2 0.0000
305 THERAPY CESSATION 1 0.0000
306 ABDOMINAL PAIN UPPER 4 0.0000
307 ABDOMINAL DISTENSION 2 0.0000
308 VOMITING 9 0.0000
309 NERVOUSNESS 1 0.0000
310 HAEMORRHAGE 2 0.0000
311 ECZEMA 1 0.0000
312 SPEECH DISORDER 1 0.0000
313 DRUG INTERACTION 3 0.0000
314 BRADYCARDIA 1 0.0000
315 DISTURBANCE IN ATTENTION 1 0.0000
316 RASH PRURITIC 1 0.0000
317 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
318 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
319 HAEMATOCHEZIA 1 0.0000
320 URTICARIA 3 0.0000
321 PANCYTOPENIA 1 0.0000
322 NECK PAIN 1 0.0000
323 BLISTER 1 0.0000
324 TOXICITY TO VARIOUS AGENTS 3 0.0000
325 HYPONATRAEMIA 1 0.0000
326 EYE PAIN 1 0.0000
327 URINARY TRACT INFECTION 3 0.0000
328 HERPES ZOSTER 1 0.0000
329 EYE IRRITATION 1 0.0000
330 SEIZURE 2 0.0000
331 DYSPHONIA 1 0.0000
332 BLADDER CANCER 1 0.0000
333 PAIN IN EXTREMITY 5 0.0000
334 THERAPEUTIC RESPONSE DECREASED 1 0.0000
335 STOMATITIS 1 0.0000
336 PLEURAL EFFUSION 1 0.0000
337 MUSCLE SPASMS 3 0.0000
338 NASOPHARYNGITIS 3 0.0000
339 EXPOSURE DURING PREGNANCY 1 0.0000
340 LOSS OF CONSCIOUSNESS 2 0.0000
341 DEEP VEIN THROMBOSIS 1 0.0000
342 SWELLING FACE 1 0.0000
343 INFUSION RELATED REACTION 1 0.0000
344 PRODUCT QUALITY ISSUE 2 0.0000
345 NEUTROPENIA 2 0.0000
346 ANXIETY 4 0.0000
347 MOBILITY DECREASED 1 0.0000
348 INFECTION 2 0.0000
349 RASH 6 0.0000
350 CONSTIPATION 3 0.0000
351 UNDERDOSE 1 0.0000
352 MALAISE 6 0.0000
353 WEIGHT INCREASED 3 0.0000
354 EPISTAXIS 1 0.0000
355 UNEVALUABLE EVENT 1 0.0000
356 ACNE 1 0.0000
357 CHRONIC KIDNEY DISEASE 1 0.0000
358 CONDITION AGGRAVATED 4 0.0000
359 DIABETES MELLITUS 1 0.0000
360 ACUTE KIDNEY INJURY 2 0.0000
361 BACK PAIN 3 0.0000
362 DRUG DOSE OMISSION BY DEVICE 1 0.0000
363 HEADACHE 8 0.0000
364 PARAESTHESIA 2 0.0000
365 NAUSEA 10 0.0000
366 INJECTION SITE BRUISING 1 0.0000
367 INJECTION SITE HAEMORRHAGE 1 0.0000
368 THROMBOSIS 1 0.0000
369 DYSPNOEA 7 0.0000
370 DRY MOUTH 1 0.0000
371 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
372 ABDOMINAL DISCOMFORT 2 0.0000
373 PRODUCT STORAGE ERROR 1 0.0000
374 PAIN 7 0.0000
375 INSOMNIA 3 0.0000
376 ADVERSE DRUG REACTION 1 0.0000
377 ADVERSE EVENT 1 0.0000
378 OROPHARYNGEAL PAIN 1 0.0000
379 HYPERSENSITIVITY 2 0.0000
380 CONTUSION 1 0.0000
381 DRUG INTOLERANCE 1 0.0000
382 ATRIAL FIBRILLATION 1 0.0000
383 HEART RATE INCREASED 1 0.0000
384 HYPOTENSION 2 0.0000
385 SOMNOLENCE 2 0.0000
386 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
387 FLUSHING 1 0.0000
388 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
389 HAEMOGLOBIN DECREASED 1 0.0000
390 OVERDOSE 2 0.0000
391 OFF LABEL USE 8 0.0000
392 FALL 3 0.0000
393 INFLUENZA 1 0.0000
394 ASTHMA 1 0.0000
395 PALPITATIONS 1 0.0000
396 EMOTIONAL DISTRESS 1 0.0000
397 VISUAL IMPAIRMENT 1 0.0000
398 PRURITUS 3 0.0000
399 HYPERHIDROSIS 1 0.0000
400 DRUG INEFFECTIVE 10 0.0000
401 RENAL FAILURE 1 0.0000
402 VISION BLURRED 1 0.0000
403 ARTHRALGIA 3 0.0000
404 INJECTION SITE PAIN 2 0.0000
405 HOSPITALISATION 1 0.0000
406 DRUG DOSE OMISSION 1 0.0000
407 TREMOR 1 0.0000
408 CEREBROVASCULAR ACCIDENT 1 0.0000
409 DEATH 5 0.0000
410 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
411 NO ADVERSE EVENT 1 0.0000
412 BLOOD GLUCOSE INCREASED 1 0.0000
413 INCORRECT DOSE ADMINISTERED 1 0.0000
414 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
415 COUGH 1 0.0000
416 PNEUMONIA 1 0.0000